Amanote Research

Amanote Research

    RegisterSign In

Derisking Psychiatric Drug Development

Journal of Clinical Psychopharmacology - United States
doi 10.1097/jcp.0000000000000536
Full Text
Open PDF
Abstract

Available in full text

Categories
PsychiatryMental HealthPharmacology
Date

October 1, 2016

Authors
Margaret C. GrabbAlan J. CrossWilliam Z. PotterJames T. McCracken
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

Potential Drug-Drug Interactions in the Psychiatric Hospital: Frequency Analysis

Research Results in Pharmacology
2019English

Urine Drug Screens: Considerations for the Psychiatric Pharmacist

Mental Health Clinician
2016English

Guidance Cues: Linking Drug Use in Adolescence With Psychiatric Disorders

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2018English

Cognitive Behavioural Therapy Improved Psychiatric Symptoms in Drug Refractory Schizophrenia

Evidence-based nursing
FundamentalsSkills
2000English

Prescribing Safely in Elderly Psychiatric Wards: Survey of Possible Drug Interactions

Psychiatric Bulletin
2008English

deCODE Drug Development Services

Chemical and Engineering News
Chemical Engineering
2004English

Psychiatric Co-Morbidity in Alcohol and Drug-Dependence: A Case Control Study

International Journal of Contemporary Medical Research [IJCMR]
2020English

Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling

Journal of Clinical Pharmacology
Pharmacology
2019English

Drug Development in Pemphigoid Diseases

Acta Dermato-Venereologica
DermatologyMedicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy